Enzo Biochem (ENZ)
(Delayed Data from NYSE)
$1.11 USD
-0.02 (-1.77%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.12 +0.01 (0.90%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Enzo Biochem, Inc. [ENZ]
Reports for Purchase
Showing records 41 - 55 ( 55 total )
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
OPERATIONS STREAMLINED - MODEL TWEAKED AHEAD OF 4Q10 NUMBERS.
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Laboratory Developed Tests Panel Summary
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
R&R?s Week in Review: Oncology and Stem Cell Sectors
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Price: 3.75 (08/30/2010 - Intraday), Price Target: $14.00, Market Cap(MM): 143.1, Rating: Market Outperform
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Labs Gains In-Network Access to Marquis Third Party Payor
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
FY3Q10 LAB REVENUES BUILD 2011 TO BE A TRANSFORMATIVE YEAR
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
R&R?s Week in Review: Oncology and Stem Cell Sectors
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
FY2Q10 UPDATE - NEW MDx TESTS AND SALES EXECS TO DRIVE REVENUES
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
USPTO Favors Enzo - Potential for Increased Revenues From Licensing Royalties
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R